On average, people with idiopathic hypersomnia wait years for a correct diagnosis. Studies from the United States, the Czech Republic, and India report delays of 6 to 9 years in adults, and in some patients the wait stretches even longer. If you or someone you know has been struggling with unexplained, unrelenting sleepiness and has not gotten clear answers, you are not alone. Here is what the condition actually is, and why it takes so long to name it.

What Is Idiopathic Hypersomnia

The American Academy of Sleep Medicine defines idiopathic hypersomnia, or IH, in the International Classification of Sleep Disorders (ICSD-3) as a chronic neurological condition marked by an uncontrollable need to sleep or persistent daytime sleepiness lasting at least three months, even after adequate or extended nighttime sleep. There is no other condition, medication, or sleep disorder that explains the sleepiness.

To meet the diagnosis, a person’s average sleep latency on a nap-based sleep test must be 8 minutes or less, with zero or one instances of REM sleep occurring shortly after falling asleep. Alternatively, a diagnosis can be made if someone sleeps 11 or more hours in a 24-hour period, confirmed through an overnight sleep study or a week of wrist actigraphy and a sleep diary.

In simple terms, IH is a brain-based sleep disorder that leaves people sleepy no matter how much they sleep.

What Are the Symptoms of IH

Excessive daytime sleepiness is required for the diagnosis and shows up in nearly every patient. Beyond that, symptoms vary from person to person, but the most common include:

• Long, unrefreshing naps, often over an hour, that do not leave you feeling rested
• Nighttime sleep that stretches past 9 or 10 hours and still feels incomplete
• Trouble focusing, thinking clearly, or holding attention during the day
• Sleep inertia, also called sleep drunkenness. This is extreme difficulty waking up, sometimes needing several alarms or help from another person, along with confusion, grogginess, or irritability after waking
• Restlessness or constant fidgeting, which some patients use as a way to stay alert
• Frequent headaches
• Memory gaps or “blackout” nights, where a person has no memory of anything during sleep
• Occasional hallucinations or sleep paralysis around sleep onset or waking, though these are less common than in narcolepsy
• Vivid dreams or nightmares
• Autonomic symptoms, such as lightheadedness on standing, or trouble regulating body temperature

Fatigue is not always reported, since it can be hard for patients to tell it apart from sleepiness itself.

What Age Does IH Usually Start

IH typically begins during adolescence or early adulthood. That said, onset has been documented as early as infancy and as late as the mid-30s. Once it starts, IH tends to follow a lifelong course, though the pattern can look different from one patient to the next.

How Common Is IH

IH is considered a rare disorder. Estimates place it at roughly 2 to 10 cases per 100,000 people, depending on which diagnostic criteria are used. Because the condition is so often missed or misdiagnosed, the true number of people living with it is likely higher than what gets recorded.

Can IH Go Away

Sometimes, but it is not the norm. Research suggests that somewhere between 11% and 33% of patients experience remission over time. In one long-term study, patients without long nighttime sleep were more likely to have a stable or improving course than those with long sleep (83% versus 61%). People with long sleep time were also more likely to have symptoms that resisted standard treatment.

It is worth noting that some cases labeled as “remission” may actually reflect an incorrect diagnosis in the first place, since testing for IH is imperfect. Most people should expect IH to be a long-term condition that needs ongoing management rather than a problem that resolves on its own.

How Can IH Affect Daily Life

IH touches nearly every part of a person’s routine. Because sleep inertia makes mornings so difficult, people are often late to school or work and may need someone else to help wake them up. This can lead to job loss, career setbacks, or reduced income. More than a third of people with hypersomnia report that their condition has interfered with their employment.

Quality of life scores are lower across most areas measured, including physical function, emotional well-being, energy, and social functioning, with effects similar in size to what is seen in narcolepsy. Relationships can suffer too. Some patients report being forced to move or even separate from a partner because of the impact of their symptoms.

Cognitive effects are common as well. Patients frequently describe trouble concentrating, slower thinking, and memory lapses that affect school and work performance. Driving is another concern. People with IH have a higher rate of car accidents and near misses than the general population, likely tied to problems with sustained attention rather than sleepiness alone.

Depression and anxiety are also more common in people with IH than in the general population, with depression reported in roughly 13% to 36% of patients across studies, compared with about 4% to 5% of healthy adults. It is not always clear whether depression is a cause, a result, or simply travels alongside IH, but it clearly adds to the overall burden.

How Is IH Diagnosed

Diagnosing IH takes more than one test and a good deal of ruling things out. The typical process includes:

• An overnight sleep study (polysomnography) to rule out other causes of sleepiness, such as sleep apnea, and to confirm adequate opportunity for sleep
• A Multiple Sleep Latency Test the following day, which measures how quickly a person falls asleep during a series of scheduled naps
• A sleep latency of 8 minutes or less on that test, with zero or one REM periods during naps
• Or, as an alternative pathway, documentation of 11 or more hours of sleep in 24 hours, measured with an overnight sleep study or with actigraphy and a sleep diary kept over at least a week
• Ruling out narcolepsy, insufficient sleep, medication or substance effects, and other medical or psychiatric causes of sleepiness

Because none of these tests are perfect on their own, doctors weigh the full clinical picture, including symptom history, sleep patterns, and how a person functions during the day.

What Are the Diagnostic Challenges of IH

IH is notoriously hard to pin down, and this is one of the biggest reasons diagnosis takes so long. A few key challenges stand out:

Overlap with narcolepsy type 2. IH shares many features with narcolepsy type 2, including excessive sleepiness without cataplexy and normal orexin levels. Current sleep tests often cannot reliably tell the two apart, and some researchers have proposed folding them into a single category.

Unreliable testing. The Multiple Sleep Latency Test, the main objective tool used for diagnosis, has poor test-retest reliability. In one study, diagnoses changed in half of patients when the test was repeated years later, simply because results shifted from one occasion to the next. Results also do not always match how sleepy a patient reports feeling day to day.

No confirmed biomarker. Unlike narcolepsy type 1, which can be confirmed with low orexin levels in spinal fluid, IH has no reliable biological marker. Diagnosis remains one of exclusion, meaning doctors must rule out every other possible cause before landing on IH.

Overlap with psychiatric hypersomnia. Hypersomnia linked to depression or other mood disorders can look very similar to IH, and the two frequently coexist, which complicates the picture further.

Undisclosed substance use. Studies that added urine drug screening to sleep testing found that 10% to 20% of patients had undisclosed drug use, including stimulants, cannabis, or sedatives, that could account for their sleep test results. Most physicians had not suspected this beforehand.

Outdated classification system. The current diagnostic manual has been criticized for not clearly distinguishing between IH and related disorders, and for lacking guidance on how to grade symptom severity. Researchers have proposed newer classification systems, but none has been formally adopted yet.

Together, these gaps in testing and classification explain why so many patients spend years bouncing between appointments before getting a name for what they are experiencing. Better biomarkers and updated diagnostic criteria are active areas of ongoing research.

---

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may have idiopathic hypersomnia, talk with a sleep medicine specialist.

Further Reading

References

1. Boulanger T, Pigeon P, Crawford S. Diagnostic challenges and burden of idiopathic hypersomnia: a systematic literature review. Sleep Advances. 2024;5:zpae059. doi:10.1093/sleepadvances/zpae059
2. American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.
3. Rassu AL, Evangelista E, Barateau L, et al. Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and their consequences in idiopathic hypersomnia. J Clin Sleep Med. 2022;18(2):617-629. doi:10.5664/jcsm.9682
4. Nevsimalova S, Susta M, Prihodova I, Horvat EM, Milata M, Sonka K. Idiopathic hypersomnia: a homogeneous or heterogeneous disease? Sleep Med. 2021;80:86-91. doi:10.1016/j.sleep.2021.01.031
5. Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, et al. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study. Lancet Neurol. 2022;21(1):53-65. doi:10.1016/S1474-4422(21)00368-9
6. Trotti LM, Ong JC, Plante DT, Friederich Murray C, King R, Bliwise DL. Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation registry. Sleep Med. 2020;75:343-349. doi:10.1016/j.sleep.2020.08.034
7. Kim T, Lee JH, Lee CS, Yoon IY. Different fates of excessive daytime sleepiness: survival analysis for remission. Acta Neurol Scand. 2016;134(1):35-41. doi:10.1111/ane.12504
8. Wasling HB, Bornstein A, Wasling P. Quality of life and procrastination in post-H1N1 narcolepsy, sporadic narcolepsy and idiopathic hypersomnia, a Swedish cross-sectional study. Sleep Med. 2020;76:104-112. doi:10.1016/j.sleep.2020.10.014
9. Schneider LD, Stevens J, Husain AM, et al. Symptom severity and treatment satisfaction in patients with idiopathic hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE). Nat Sci Sleep. 2023;15:89-101. doi:10.2147/NSS.S386021
10. Lammers GJ, Bassetti CLA, Dolenc-Groselj L, et al. Diagnosis of central disorders of hypersomnolence: a reappraisal by European experts. Sleep Med Rev. 2020;52:101306. doi:10.1016/j.smrv.2020.101306